Raffles Medical Group Ltd
SGX:BSL

Watchlist Manager
Raffles Medical Group Ltd Logo
Raffles Medical Group Ltd
SGX:BSL
Watchlist
Price: 0.835 SGD 0.6% Market Closed
Market Cap: 1.6B SGD
Have any thoughts about
Raffles Medical Group Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one BSL stock under the Base Case scenario is 1.064 SGD. Compared to the current market price of 0.835 SGD, Raffles Medical Group Ltd is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BSL Relative Value
Base Case
1.064 SGD
Undervaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.2
P/S
P/S
Price to Sales
2.2
vs History
98
vs Industry
42
Median 3Y
3
Median 5Y
3
Industry
2.3
Forward
2.1
More Details
25.4
P/E
P/E
Price to Earnings
25.4
vs History
38
vs Industry
27
Median 3Y
22.3
Median 5Y
25.5
Industry
23.1
Forward
21.2
More Details
16
P/OCF
P/OCF
Price to OCF
16
vs History
12
vs Industry
35
Median 3Y
13.1
Median 5Y
13.5
Industry
14.2
More Details
27.6
P/FCFE
P/FCFE
Price to FCFE
27.6
vs History
30
vs Industry
31
Median 3Y
25.4
Median 5Y
24.4
Industry
20.1
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
92
vs Industry
45
Median 3Y
2.3
Median 5Y
2.2
Industry
2.2
More Details
2
EV/S
EV/S
Enterprise Value to Sales
2
vs History
98
vs Industry
44
Median 3Y
2.7
Median 5Y
2.9
Industry
2.4
Forward
1.9
More Details
2.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.2
vs History
98
vs Industry
62
Median 3Y
3.2
Median 5Y
3.5
Industry
5
More Details
11.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.9
vs History
55
vs Industry
29
Median 3Y
11.8
Median 5Y
12.9
Industry
12.7
Forward
10.6
More Details
17.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
17.7
vs History
47
vs Industry
28
Median 3Y
15.7
Median 5Y
18.2
Industry
17.1
Forward
15.2
More Details
14.7
EV/OCF
EV/OCF
Enterprise Value to OCF
14.7
vs History
14
vs Industry
38
Median 3Y
12.3
Median 5Y
13
Industry
14
More Details
19.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.7
vs History
50
vs Industry
33
Median 3Y
14.5
Median 5Y
20.6
Industry
18
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
88
vs Industry
41
Median 3Y
2
Median 5Y
1.9
Industry
1.9
More Details

Multiples Across Competitors

BSL Competitors Multiples
Raffles Medical Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SG
Raffles Medical Group Ltd
SGX:BSL
1.6B SGD 2.2 25.4 11.9 17.7
US
HCA Healthcare Inc
NYSE:HCA
78.1B USD 1.1 13.2 8.3 10.8
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 9.3 44 39 45.3
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
24.1B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
20B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
129.8B CNY 6.3 35.8 27 27
MY
IHH Healthcare Bhd
KLSE:IHH
63.4B MYR 2.7 23.9 12.9 18.7
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 19.8 106.6 73.9 88.1
US
Tenet Healthcare Corp
NYSE:THC
12.2B USD 0.6 3.9 5.2 6.6
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 5.3 100.7 42 57.5
US
Universal Health Services Inc
NYSE:UHS
11.9B USD 0.8 11.6 7.8 10.7

See Also

Summary
BSL intrinsic value, competitors valuation, and company profile.
DCF Valuation
BSL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BSL stock valuation using valuation multiples.
Wall Street Estimates
BSL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BSL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.